NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/01/2024
Voltar para busca
Dado oficial do USPTO
SILENT DESIGN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
SILENT DESIGN
ST13
US500000088232438Classe
1, 5
Pedido
88232438
Registro
7265521
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
63
Atualização mais recente
09/01/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
17/12/2018
Data de registro
09/01/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/01/2024
Última transação
09/01/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
Kobe, Hyogo, JP
Examinador
ANKRAH, NAAKWAMA S
Unidade examinadora
L90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
S. C. (pessoa física)
Representantes
Jennifer Theis CROWELL & MORING
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical reagents other than for medical or veterinary purposes; chemical preparations for scientific purposesincluding non-therapeutic ingredients used in pharmaceutical manufacture; diagnostic chemicals for scientific or research usereagents used in laboratory for scientific purposes; diagnostic reagents and diagnostic preparationsother than for medical or veterinary purposes; reagents for hematology analysis for scientific or research use; reagents for reticulocyte analysis for scientific or research use; reagents for blood coagulation analysis for scientific or research use; reagents for urinalysis for scientific or research use; reagents for immunoassay for scientific or research use; reagents for clinical chemistry testing for scientific or research use; reagents for gene test for scientific or research use; lysing solutionsreagents used for hemolysing whole blood sample for scientific purposes; chemical reagent stains for industrial use; chemicalssheath solutions for industrial use; reference control chemicals for industrial use; chemical reference materials for industrial use; chemical agentsquality control standard solutions and quality control chemicals for industrial use for testing and calibrating medical apparatus and reagents; hematology control chemicals for testing and calibrating medical apparatus and reagents; hematology control chemicals for industrial use; standard serum for scientific or research use; control serum for scientific or research use; biochemical standard serum for scientific or research use; biochemical control serum for scientific or research use; chemical agentsquality control standard solutions and quality control chemicals for testing and calibrating medical apparatus and reagents; stains for medical or clinical laboratory use; stains for hematology analysis for medical or clinical laboratory use; stains for reticulocyte analysis for medical or clinical laboratory use; stains for urinalysis for medical or clinical laboratory use; stains for immunoassay for medical or clinical laboratory use
Classe 5
Sanitary preparations for medical use; diagnostic reagents and diagnostic preparations for medical or veterinary purposes; chemical reagents for medical or veterinary purposes; testing reagents for clinical medical or medical diagnostic use; reagents for hematology analysis for clinical medical or medical diagnostic use; reagents for blood analysis for clinical medical or medical diagnostic use; reagents for white blood cell analysis for clinical medical or medical diagnostic use; reagents for immature cell analysis for clinical medical or medical diagnostic use; reagents for hemoglobin analysis for clinical medical or medical diagnostic use; reagents for reticulocyte analysis for clinical medical or medical diagnostic use; reagents for erythrocyte analysis for clinical medical or medical diagnostic use; reagents for nucleated red cell analysis for clinical medical or medical diagnostic use; reagents for blood coagulation analysis for medical or veterinary purposes; reagents for urinalysis for medical or veterinary purposes; reagents for urinary sediment analysis for medical or veterinary purposes; reagents for immunoassay for medical or veterinary purposes; reagents for bacteria analysis for medical or veterinary purposes; reagents for clinical chemistry testing for medical or veterinary purposes; reagents for genetic test for medical or veterinary purposes; reagents for protein test for medical or veterinary purposes; reagents for cancer recurrence prediction test for medical or veterinary purposes; reagents for anticancer drug sensitivity prediction test for medical or veterinary purposes; diluents for clinical medical or medical diagnostic use; diluents for hematology analysis for medical or veterinary purposes; diluents for reticulocyte analysis for medical or veterinary purposes; diluents for urinalysis for medical or veterinary purposes; diluents for immunoassay for medical or veterinary purposes; medical diagnostic reagents and solutionslysing solutions and reagents and hemolytic lysing solutions and reagents for hemolysing whole blood sample for medical or veterinary purposes; medical diagnostic reagents and solutionssheath solutions to be used in detecting analyte using flow cytometry for medical use; hematology control reagents for medical use; reference control reagents for medical use
Publicações
Histórico de despachos e eventos da marca no USPTO.
63 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
09/01/2024
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
05/12/2023
IUCN
NOTICE OF ALLOWANCE CANCELLED
05/10/2023
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
05/10/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
18/04/2023
EX5G
SOU EXTENSION 5 GRANTED
17/04/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
17/04/2023
EXT5
SOU EXTENSION 5 FILED
12/04/2023
EEXT
SOU TEAS EXTENSION RECEIVED
12/04/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/11/2022
EX4G
SOU EXTENSION 4 GRANTED
07/11/2022
EXT4
SOU EXTENSION 4 FILED
07/11/2022
EEXT
SOU TEAS EXTENSION RECEIVED
07/11/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/05/2022
EX3G
SOU EXTENSION 3 GRANTED
02/05/2022
EXT3
SOU EXTENSION 3 FILED
02/05/2022
EEXT
SOU TEAS EXTENSION RECEIVED
02/05/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/11/2021
EX2G
SOU EXTENSION 2 GRANTED
10/11/2021
EXT2
SOU EXTENSION 2 FILED
10/11/2021
EEXT
SOU TEAS EXTENSION RECEIVED
10/11/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/05/2021
EX1G
SOU EXTENSION 1 GRANTED
07/05/2021
EXT1
SOU EXTENSION 1 FILED
07/05/2021
EEXT
SOU TEAS EXTENSION RECEIVED
07/05/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/12/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
13/10/2020
PUBO
PUBLISHED FOR OPPOSITION
13/10/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
23/09/2020
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
10/09/2020
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
04/09/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/09/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/09/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/09/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/09/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
31/03/2020
GNRT
NON-FINAL ACTION E-MAILED
31/03/2020
CNRT
NON-FINAL ACTION WRITTEN
31/03/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/03/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/03/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
04/03/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/01/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
21/11/2019
GNSI
INQUIRY TO SUSPENSION E-MAILED
21/11/2019
CNSI
SUSPENSION INQUIRY WRITTEN
21/11/2019
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
06/11/2019
ALIE
ASSIGNED TO LIE
29/10/2019
ALIE
ASSIGNED TO LIE
15/10/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
26/03/2019
GNSL
LETTER OF SUSPENSION E-MAILED
26/03/2019
CNSL
SUSPENSION LETTER WRITTEN
26/03/2019
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
26/03/2019
ISSR
WITHDRAWN FROM ISSUE - SENIOR ATTORNEY REQUEST
26/03/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26/03/2019
PUBO
PUBLISHED FOR OPPOSITION
26/03/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/03/2019
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
20/02/2019
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
15/02/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/02/2019
DOCK
ASSIGNED TO EXAMINER
31/01/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/01/2019
NWAP
NEW APPLICATION ENTERED
20/12/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SILENT DESIGN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.